Integrated Diagnostics Holdings - IDH

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group’s core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Lab (Nigeria). A long track record for quality and safety has earned the company a trusted reputation, as well as internationally recognized accreditations for its portfolio of over 1,400 diagnostics tests. From its base of 471 branches as of 30 September 2020. Beyond organic growth, the group’s expansion plans include acquisitions in new Middle Eastern and African markets where its model is well-suited to capitalize on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015. The Company aims to be a leading healthcare provider in every community and region that it serves, becoming every doctor and patient’s first choice for quality, accurate diagnostic testing and cost-effective services. One of IDH’s philosophies is its strict adherence to providing accurate and timely diagnostic services, which is why we accredit our laboratories through stringent international bodies such as College of American Pathologists (CAP) and the International Organization for Standardization (ISO). The Company remains committed to its core values of providing patient-focused care, supporting and enhancing its medical staff’s education and training, acquiring and sharing information effectively, while developing and strengthening its relationships with patients, employees and business partners. IDH is also bound to its ethical values that emphasize integrity and fairness, as it strives for superior operational and financial performance.